Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Inflammation and Regeneration|April 11, 2026
Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophiesFarah Gamal Abdelrehim, Zade Sadek, Salma A Fahim, et al.
FEBS Open Bio|May 8, 2013
Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4Nada El-Ekiaby, Nabila Hamdi, Mohamed Negm, et al.
Seminars in Liver Disease|June 27, 2019
Competing Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of RivalryAbdelrahman Yousry Afify, Salma Abdulmaqsoud Ibrahim, Mennah Hisham Aldamsisi, et al.
Frontiers in Medicine|October 7, 2022
Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAsShereen A El Sobky, Nourhan K Aboud, Nihal M El Assaly, et al.
Transfusion|September 8, 2017
A randomized multicenter study: safety and efficacy of mini-pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1-18 years with immune thrombocytopeniaMohsen Elalfy, Marwa Reda, Islam Elghamry, et al.
Frontiers in Genetics|April 5, 2018
Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell ModelsSarah E Riad, Dalia S Elhelw, Heba Shawer, et al.
Archives of Virology|March 25, 2018
Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of OccludinDalia S Elhelw, Sarah E Riad, Heba Shawer, et al.
Archives of Virology|June 24, 2017
Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of OccludinDalia S Elhelw, Sarah E Riad, Heba Shawer, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 3, 2020
MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 CellsMohamed A Ragheb, Marwa H Soliman, Emad M Elzayat, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 18, 2020
MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular CarcinomaMarwa H Soliman, Mohamed A Ragheb, Emad M Elzayat, et al.
Pageof 3